Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Magnit opened a store M City in foodmall Three Vokzala. Depot

1/20/25 MGNT

Etalon enters the market of Kaliningrad region

1/20/25 ETLN

VMTP renews record in container turnover

1/20/25 FESH

Samolet will build its first five-star hotel in the Tver Region

1/20/25 SMLT

Element bought 50% of the MIPT Internet provider

1/20/25 ELMT

VTB to open a full-fledged bank in Iran

1/17/25 VTBR

Container transportation by Fesco Baltorient Line service increased 3 times

1/17/25 FESH

Sberbank reported for 2024 by RAS

1/17/25 SBER

Samolet is conducting a bond buyback

1/16/25 SMLT

Etalon started selling apartments in Residential Complex Cranberry.Park

1/16/25 ETLN